Brief: Alligator Bioscience, Orion Corporation Announce Exercise Of Development Option
11/05/2023 13:46
May 11 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR BIOSCIENCE AND ORION CORPORATION ANNOUNCE
EXERCISE OF
DEVELOPMENT OPTION UNDER THEIR 2021 IMMUNO-ONCOLOGY RESEARCH
COLLABORATION AND LICENSE AGREEMENT
Source text for Eikon: ID:nMFN7w8rKK
Further company coverage: 271560.KS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln